A prospective observational study conducted in France to describe routine clinical practice for treatment naïve or previously treated patients with diabetic macular edema (DME) who are starting IVT aflibercept (APOLLON)

First published 03/10/2016

Last updated 02/07/2024

EU PAS number:

EUPAS15687

Study

Finalised

Documents

Study protocol

Initial protocol

18636_Protocol_APOLLON_version 1.1_29Feb2016

English (1005.58 KB - PDF)View document

Updated protocol

Protocol APOLLON_V2.0_13012017_Bayer

First published: 22/02/2024

English (801.77 KB - PDF)View document

Study results

18636_EU PAS Abstract_Redacted_Version 1.0_2020-07-06

English (633.48 KB - PDF)View document

Study report

18636_Clinical Study Report_Redacted_Version 1.0_2020-07-06

English (9.74 MB - PDF)View document

18636_Interim report_V1.0_2018-07-03

English (2.69 MB - PDF)View document

Other information

Study, other information

18636_Interim report_V1.0_2018-07-03.pdf

English (2.69 MB - PDF)View document

ENCePP Seal

ENCePP Seal documents

Secondary tabs